Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Wake Forest University School of Medicine - Internal Medicine/Endocrinology
mi
from
Winston-Salem, NC
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Wake Forest University School of Medicine - Internal Medicine/Endocrinology
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Sterling Research Group
mi
from
Cincinnati, OH
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Sterling Research Group
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
St Vincent Charity Hospital - The Center for Vascular Health
mi
from
Cleveland, OH
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
St Vincent Charity Hospital - The Center for Vascular Health
mi
from
Cleveland, OH
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
North Ohio Research, Ltd.
mi
from
Sandusky, OH
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
North Ohio Research, Ltd.
mi
from
Sandusky, OH
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Portland VA Medical Center
mi
from
Portland, OR
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Portland VA Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Pennsylvania Cardiology Associates
mi
from
Philadelphia, PA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Pennsylvania Cardiology Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Cardiology Consultants of Philadelphia
mi
from
Philadelphia, PA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Cardiology Consultants of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Women's Cardiac Center at The Miriam Hospital
mi
from
Providence, RI
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Women's Cardiac Center at The Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Internal Medicine Associates of Greenville
mi
from
Greenville, SC
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Internal Medicine Associates of Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
VAMC Memphis - Hypertension/Lipid Research Clinic
mi
from
Memphis, TN
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
VAMC Memphis - Hypertension/Lipid Research Clinic
mi
from
Memphis, TN
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Kelsey Research Foundation
mi
from
Houston, TX
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Kelsey Research Foundation
mi
from
Houston, TX
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Baylor College of Medicine
mi
from
Houston, TX
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Methodist Hospital
mi
from
Houston, TX
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Intermountain Medical Center
mi
from
Murray, UT
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
University of Virginia - UVA Cardiology
mi
from
Charlottesville, VA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
University of Virginia - UVA Cardiology
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Mcguire Va Medical Center
mi
from
Richmond, VA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Mcguire Va Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
University of Washington, Northwest Lipid Research Center
mi
from
Seattle, WA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
University of Washington, Northwest Lipid Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
University of Washington Coronary Atherosclerosis Research Lab
mi
from
Seattle, WA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
University of Washington Coronary Atherosclerosis Research Lab
mi
from
Seattle, WA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
VA Cardiology Research
mi
from
Seattle, WA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
VA Cardiology Research
mi
from
Seattle, WA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Washington State University
mi
from
Spokane, WA
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Washington State University
mi
from
Spokane, WA
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
CaRE Foundation, Inc
mi
from
Wausau, WI
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
CaRE Foundation, Inc
mi
from
Wausau, WI
Click here to add this to my saved trials
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated:  3/8/2016
Heart Health Institute
mi
from
Calgary,
Niacin Plus Statin to Prevent Vascular Events
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
Status: Enrolling
Updated: 3/8/2016
Heart Health Institute
mi
from
Calgary,
Click here to add this to my saved trials
Comparison of Gabapentin and Pregabalin for Radicular Pain
Comparison of Gabapentin and Pregabalin for Cervical and Lumbar Radicular Pain
Status: Enrolling
Updated:  3/8/2016
Emory Orthopaedics & Spine Center
mi
from
Atlanta, GA
Comparison of Gabapentin and Pregabalin for Radicular Pain
Comparison of Gabapentin and Pregabalin for Cervical and Lumbar Radicular Pain
Status: Enrolling
Updated: 3/8/2016
Emory Orthopaedics & Spine Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Status: Enrolling
Updated:  3/9/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Status: Enrolling
Updated: 3/9/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Music Therapy/Physical Therapy Intervention to Enhance Well-being and Functional Recovery Post-stroke
A Collaborative Music Therapy/Physical Therapy Intervention to Enhance Well-being and Functional Recovery Post-stroke
Status: Enrolling
Updated:  3/9/2016
New York University School of Medicine
mi
from
New York, NY
Music Therapy/Physical Therapy Intervention to Enhance Well-being and Functional Recovery Post-stroke
A Collaborative Music Therapy/Physical Therapy Intervention to Enhance Well-being and Functional Recovery Post-stroke
Status: Enrolling
Updated: 3/9/2016
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia
Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia: A Randomized, Double-Blind Placebo-Controlled Cross-Over Study
Status: Enrolling
Updated:  3/9/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia
Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia: A Randomized, Double-Blind Placebo-Controlled Cross-Over Study
Status: Enrolling
Updated: 3/9/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
A Phase l, Open-label, First in Human, Feasibility and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  3/9/2016
Emory University
mi
from
Atlanta, GA
Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
A Phase l, Open-label, First in Human, Feasibility and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 3/9/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Decatur Memorial Hospital
mi
from
Decatur, IL
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Decatur Memorial Hospital
mi
from
Decatur, IL
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Ingalls Memorial Hospital
mi
from
Harvey, IL
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Ingalls Memorial Hospital
mi
from
Harvey, IL
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Joliet Oncology-Hematology Associates Limited
mi
from
Joliet, IL
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Joliet Oncology-Hematology Associates Limited
mi
from
Joliet, IL
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Central Illinois Hematology Oncology Center
mi
from
Springfield, IL
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Central Illinois Hematology Oncology Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
NorthShore University HealthSystem-Evanston Hospital
mi
from
Evanston, IL
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
NorthShore University HealthSystem-Evanston Hospital
mi
from
Evanston, IL
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Loyola University Medical Center
mi
from
Maywood, IL
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Fort Wayne Medical Oncology and Hematology Inc-Parkview
mi
from
Fort Wayne, IN
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Fort Wayne Medical Oncology and Hematology Inc-Parkview
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated:  3/10/2016
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/10/2016
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Woodland Northwest Research, LLC
mi
from
Springdale, AR
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Woodland Northwest Research, LLC
mi
from
Springdale, AR
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
World Wide Research Centers Inc.
mi
from
Murrietta, CA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
World Wide Research Centers Inc.
mi
from
Murrietta, CA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
mi
from
Cincinnati, OH
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Segal Institute for Clinical Research
mi
from
Ft. Lauderdale, FL
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Segal Institute for Clinical Research
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Miami Children's Hospital
mi
from
South Miami, FL
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Miami Children's Hospital
mi
from
South Miami, FL
Click here to add this to my saved trials